DNA-binding parameters of daunorubicin and doxorubicin in the conditions used for studying the interaction of anthracycline-DNA complexes with cells in vitro
- 1 January 1979
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 2 (1) , 7-10
- https://doi.org/10.1007/bf00253097
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Clinical trials with daunorubicin-DNA and adriamycin-DNA in acute lymphoblastic leukemia of childhood, acute nonlymphoblastic leukemia, and bronchogenic carcinoma.1979
- Comparative study in mice of the toxicity, pharmacology, and therapeutic activity of daunorubicin-DNA and doxorubicin-DNA complexesCancer Chemotherapy and Pharmacology, 1979
- Comparative studies on the in vitro killing of human normal and leukemic clonogenic cells (CFUc) by daunorubicin, daunorubicinol, and daunorubicin-DNA complexCancer Chemotherapy and Pharmacology, 1979
- Uptake of the daunorubicin-DNA complex in cultured fibroblastsCancer Chemotherapy and Pharmacology, 1979
- Adriamycin and adriamycin—DNA in inoperable bronchogenic carcinoma. A randomized study with cyclophosphamide vinblastinePublished by Elsevier ,1978
- Uptake and subcellular localization of daunorubicin and adriamycin in cultured fibroblastsPublished by Elsevier ,1978
- Cytostatic efficacy of DNA-complexes of adriamycin, daunomycin and actinomycin DZeitschrift für Krebsforschung und Klinische Onkologie, 1977
- Thermodynamics of the interaction of daunomycin with DNABiophysical Chemistry, 1977
- Experimental leukemia chemotherapy with a “lysosomotropic” adriamycin-DNA complexPublished by Elsevier ,1974